AN2 Therapeutics, Inc. (ANTX) Misses Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts ANTX Hot Sheet
Join SI Premium – FREE
AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q1 EPS of ($0.35), $0.10 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- General Mills (GIS) Tops Q1 EPS by 3c
- iShares 20+ Year Treasury Bond ETF (TLT) call put ratio 1.4 calls to 1 put as rates increase
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
